MYDA Advisors’s Context Therapeutics CNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$75.1K Buy
+250,000
New +$123K 0.01% 197

Other funds holding CNTX

MYDA Advisors's CNTX Position: Q3 2026 in Review

MYDA Advisors opened a new position in Context Therapeutics (CNTX) in Q3 2026: 250,000 shares worth $75.1K. The stake represents 0.01% of the portfolio and ranks #197 among its holdings.

87 funds tracked by Wall St. Rank hold CNTX as of Q3 2026.

  • MYDA Advisors held 250,000 shares of Context Therapeutics worth $75.1K as of Q3 2026.
  • Context Therapeutics was a new MYDA Advisors position in Q3 2026.
  • Context Therapeutics made up 0.01% of MYDA Advisors's portfolio in Q3 2026, its #197 holding.
  • 87 funds tracked by Wall St. Rank held Context Therapeutics as of Q3 2026.

Based on MYDA Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.